Annual EBITDA
$14.58B$1.16B+8.60%
Summary
- Current Value
- As of today, GILD annual EBITDA is $14.58B, up +8.60% on
- Historical Performance
- GILD annual EBITDA is up +13.39% over the past 3 years, up +22.29% over the past 5 years
- All-Time High Comparison
- GILD annual EBITDA is currently -35.73% below its historical high of $22.69B set on
- 3-Year Low Comparison
- GILD annual EBITDA is +17.25% above its 3-year low of $12.44B reached on
- Sector Comparison
- GILD annual EBITDA is higher than 98.80% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $14.58B | +8.6% | +13.4% | +22.3% | +248.9% | |
| Quarterly EBITDA | $3.45B | +6.4% | +23.2% | -0.4% | +254.4% | |
| TTM EBITDA | $14.77B | +8.0% | +16.6% | +19.5% | +276.6% | |
| Price | $130.37 | +19.5% | +65.3% | +88.0% | +536.3% | |
| PE Ratio | 17.74 | -22.7% | -0.5% | -94.2% | +38.0% | |
| Annual Revenue | $29.45B | +2.5% | +8.7% | +19.5% | +273.9% | |
| Annual EPS | $6.78 | +1672.8% | +86.4% | +6861.9% | +308.3% | |
| Annual EBIT | $11.82B | +10.8% | +9.8% | +13.2% | +201.9% | |
| Annual Net Income | $8.51B | +1672.9% | +86.4% | +9461.8% | +194.5% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $14.58B | at high | |
| 5Y | $14.58B | at high | |
| All | $22.69B | -35.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $12.44B | +17.3% | |
| 5Y | $11.92B | N/A | +22.3% |
| All | -$104.60M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of GILD?
As of today, GILD annual EBITDA is $14.58B
What is 1-year change in GILD annual EBITDA?
GILD annual EBITDA is up +8.60% year-over-year
What is 3-year change in GILD annual EBITDA?
GILD annual EBITDA is up +13.39% over the past 3 years
How far is GILD annual EBITDA from its all-time high?
GILD annual EBITDA is currently -35.73% below its historical high of $22.69B set on December 31, 2015
How does GILD annual EBITDA rank versus sector peers?
GILD annual EBITDA is higher than 98.80% of companies in Healthcare sector
When is GILD next annual earnings release?
As of today, the next annual earnings release for GILD has not been scheduled
Quarterly EBITDA
$3.45B$212.00M-5.79%
Summary
- Current Value
- As of today, GILD quarterly EBITDA is $3.45B, down -5.79% on
- Historical Performance
- GILD quarterly EBITDA is up +6.39% year-over-year, up +23.23% over the past 3 years
- All-Time High Comparison
- GILD quarterly EBITDA is currently -40.23% below its historical high of $5.77B set on
- 3-Year Low Comparison
- GILD quarterly EBITDA is +33.64% above its 3-year low of $2.58B reached on
- Sector Comparison
- GILD quarterly EBITDA is higher than 98.71% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $3.45B | -5.8% | +6.4% | +23.2% | -0.4% | |
| Annual EBITDA | $14.58B | – | +8.6% | +13.4% | +22.3% | |
| TTM EBITDA | $14.77B | +1.4% | +8.0% | +16.6% | +19.5% | |
| Price | $130.37 | -13.9% | +19.5% | +65.3% | +88.0% | |
| PE Ratio | 17.74 | -20.5% | -22.7% | -0.5% | -94.2% | |
| Quarterly Revenue | $6.98B | -12.2% | +5.1% | +10.4% | +8.3% | |
| Quarterly EPS | $1.61 | -7.5% | +54.3% | +101.2% | +17.6% | |
| Quarterly EBIT | $2.76B | -7.8% | +8.4% | +27.9% | -7.7% | |
| Quarterly Net Income | $2.02B | -7.4% | +53.7% | +105.2% | +17.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.22B | -18.2% | |
| 3Y | $4.22B | -18.2% | |
| 5Y | $4.36B | -20.9% | |
| All | $5.77B | -40.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.24B | N/A | +6.4% |
| 3Y | $2.58B | +33.6% | |
| 5Y | $2.00B | +72.6% | |
| All | -$1.16B | +398.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of GILD?
As of today, GILD quarterly EBITDA is $3.45B
What is GILD quarterly EBITDA most recent change?
GILD quarterly EBITDA was down -5.79% on March 31, 2026
What is 1-year change in GILD quarterly EBITDA?
GILD quarterly EBITDA is up +6.39% year-over-year
How far is GILD quarterly EBITDA from its all-time high?
GILD quarterly EBITDA is currently -40.23% below its historical high of $5.77B set on June 30, 2015
How does GILD quarterly EBITDA rank versus sector peers?
GILD quarterly EBITDA is higher than 98.71% of companies in Healthcare sector
When is GILD next earnings release?
The next earnings release for GILD is on
TTM EBITDA
$14.77B$207.00M+1.42%
Summary
- Current Value
- As of today, GILD TTM EBITDA is $14.77B, up +1.42% on
- Historical Performance
- GILD TTM EBITDA is up +7.98% year-over-year, up +16.57% over the past 3 years
- All-Time High Comparison
- GILD TTM EBITDA is currently -35.10% below its historical high of $22.76B set on
- 3-Year Low Comparison
- GILD TTM EBITDA is +24.30% above its 3-year low of $11.88B reached on
- Sector Comparison
- GILD TTM EBITDA is higher than 98.80% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $14.77B | +1.4% | +8.0% | +16.6% | +19.5% | |
| Annual EBITDA | $14.58B | – | +8.6% | +13.4% | +22.3% | |
| Quarterly EBITDA | $3.45B | -5.8% | +6.4% | +23.2% | -0.4% | |
| Price | $130.37 | -13.9% | +19.5% | +65.3% | +88.0% | |
| PE Ratio | 17.74 | -20.5% | -22.7% | -0.5% | -94.2% | |
| TTM Revenue | $29.79B | +1.1% | +3.8% | +11.0% | +16.5% | |
| TTM EPS | $7.35 | +8.4% | +54.5% | +66.1% | +3140.5% | |
| TTM EBIT | $12.04B | +1.8% | +10.4% | +15.2% | +11.9% | |
| TTM Net Income | $9.22B | +8.3% | +54.5% | +66.4% | +3275.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $14.77B | at high | |
| 3Y | $14.77B | at high | |
| 5Y | $14.77B | at high | |
| All | $22.76B | -35.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $13.68B | N/A | +8.0% |
| 3Y | $11.88B | +24.3% | |
| 5Y | $11.88B | +24.3% | |
| All | -$104.60M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of GILD?
As of today, GILD TTM EBITDA is $14.77B
What is GILD TTM EBITDA most recent change?
GILD TTM EBITDA was up +1.42% on March 31, 2026
What is 1-year change in GILD TTM EBITDA?
GILD TTM EBITDA is up +7.98% year-over-year
How far is GILD TTM EBITDA from its all-time high?
GILD TTM EBITDA is currently -35.10% below its historical high of $22.76B set on December 31, 2015
How does GILD TTM EBITDA rank versus sector peers?
GILD TTM EBITDA is higher than 98.80% of companies in Healthcare sector
When is GILD next earnings release?
The next earnings release for GILD is on
EBITDA Formula
Data Sources & References
- GILD Official Website www.gilead.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/882095/000088209526000003/0000882095-26-000003-index.htm
- GILD Profile on Yahoo Finance finance.yahoo.com/quote/GILD
- GILD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gild